E/E' Ratio Measurement and Assessment of Decongestion in Heart Failure
An E/E' ratio ≤8 indicates normal left ventricular filling pressures and confirms adequate decongestion, while values >15 definitively indicate elevated filling pressures and persistent congestion. 1
Understanding the E/E' Ratio Components
The E/E' ratio combines two distinct Doppler measurements that together provide insight into left ventricular filling pressures:
- E wave: The early diastolic transmitral flow velocity measured by conventional pulsed-wave Doppler, reflecting the pressure gradient between the left atrium and left ventricle during early diastole 2
- e' velocity: The early diastolic mitral annular velocity measured by tissue Doppler imaging (TDI), primarily reflecting left ventricular relaxation with minimal influence from loading conditions 2
Proper Measurement Technique
- Measure e' at both septal and lateral mitral annulus positions and calculate the average for optimal assessment of global diastolic function 1, 2
- Septal e' values <8 cm/s, lateral e' <10 cm/s, or average e' <9 cm/s indicate delayed LV relaxation 1
- Proper sample volume positioning at the mitral annulus is critical for accurate e' measurement 2
Interpreting E/E' for Decongestion Status
Definitive Values
E/E' <8: Indicates normal LV filling pressures and confirms the patient is well-decongested 1, 2
E/E' >15 (or >14 for average values): Indicates high LV filling pressures and persistent congestion requiring continued diuresis 1, 2
The Gray Zone (E/E' 8-15)
- Values between 8-15 are indeterminate and require additional parameters to assess filling pressures 1
- In this range, incorporate:
Clinical Application for Decongestion Assessment
At Hospital Discharge
- Target E/E' ≤15 before discharge to reduce readmission risk 3
- Patients with E/E' >15 after optimized medical therapy have significantly higher rates of heart failure readmissions and worse prognosis 3
- An E/E' threshold of approximately 13.8 has been validated as an inflection point for increased heart failure readmissions in acute HFpEF 4
Prognostic Significance
- Lower baseline E/E' in the acute phase independently predicts subsequent improvement of left ventricular ejection fraction in HFrEF patients 5
- E/E' >15 after optimized therapy is an independent predictor of cardiac events (risk ratio 6.1) in heart failure with preserved systolic function 3
- Septal E/E' at discharge has excellent accuracy (AUC 0.85) for predicting cardiac death 6
Important Caveats and Limitations
When E/E' May Be Unreliable
The E/E' ratio has limited accuracy in specific clinical scenarios 2:
- Heavy mitral annular calcification distorts tissue Doppler signals
- Mitral valve disease (stenosis or significant regurgitation) alters transmitral flow patterns
- Pericardial disease affects ventricular filling mechanics
- Regional wall motion abnormalities from coronary artery disease create heterogeneous annular velocities
- Atrial fibrillation causes beat-to-beat variability requiring averaging of multiple beats
Correlation Limitations
- The correlation between E/e' and invasively measured filling pressures is modest (r = 0.56), meaning approximately 30% of variance in filling pressures is explained by E/E' 2
- This underscores why E/E' should be integrated with other clinical and echocardiographic parameters rather than used in isolation
Practical Algorithm for Assessing Decongestion
Measure E/E' ratio (average of septal and lateral sites preferred) 1, 2
If E/E' ≤8: Patient is well-decongested; normal filling pressures confirmed 1
If E/E' >15: Patient remains congested; continue aggressive diuresis 1
If E/E' 8-15: Assess additional parameters:
Correlate with clinical assessment: jugular venous pressure, peripheral edema, orthopnea, and natriuretic peptide levels 1
The goal of decongestion therapy is achieving E/E' ≤15 (ideally <8) combined with resolution of clinical congestion signs before hospital discharge to optimize outcomes and reduce readmissions. 4, 3